Elekta AB (publ) (EKTAY)
USD 5.45
(-0.55%)
USD 5.45
(-0.55%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 21.61 Billion SEK | 3.81% |
| 2023 | 19.87 Billion SEK | 14.3% |
| 2022 | 17.38 Billion SEK | 4.44% |
| 2021 | 16.64 Billion SEK | -17.98% |
| 2020 | 20.29 Billion SEK | 24.64% |
| 2019 | 16.28 Billion SEK | 12.46% |
| 2018 | 14.48 Billion SEK | 2.16% |
| 2017 | 14.17 Billion SEK | 8.8% |
| 2016 | 13.02 Billion SEK | -10.39% |
| 2015 | 14.53 Billion SEK | 24.96% |
| 2014 | 11.63 Billion SEK | 8.26% |
| 2013 | 10.74 Billion SEK | 5.11% |
| 2012 | 10.22 Billion SEK | 99.36% |
| 2011 | 5.12 Billion SEK | -2.69% |
| 2010 | 5.27 Billion SEK | -2.32% |
| 2009 | 5.39 Billion SEK | 19.91% |
| 2008 | 4.5 Billion SEK | 28.83% |
| 2007 | 3.49 Billion SEK | 2.25% |
| 2006 | 3.41 Billion SEK | 21.78% |
| 2005 | 2.8 Billion SEK | 68.67% |
| 2004 | 1.66 Billion SEK | 9.62% |
| 2003 | 1.51 Billion SEK | 20.59% |
| 2002 | 1.25 Billion SEK | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 21.24 Billion SEK | 3.12% |
| 2024 Q3 | 20.47 Billion SEK | -3.61% |
| 2024 Q4 | 21.61 Billion SEK | 5.57% |
| 2024 FY | 21.61 Billion SEK | 8.77% |
| 2024 Q1 | 20.6 Billion SEK | 3.66% |
| 2023 Q3 | 18.34 Billion SEK | 1.38% |
| 2023 Q1 | 17.24 Billion SEK | -0.85% |
| 2023 Q4 | 19.87 Billion SEK | 8.36% |
| 2023 FY | 19.87 Billion SEK | 14.3% |
| 2023 Q2 | 18.09 Billion SEK | 4.95% |
| 2022 Q3 | 18.63 Billion SEK | 18.65% |
| 2022 Q1 | 15.82 Billion SEK | -4.93% |
| 2022 Q2 | 15.7 Billion SEK | -0.8% |
| 2022 FY | 17.38 Billion SEK | 4.44% |
| 2022 Q4 | 17.38 Billion SEK | -6.67% |
| 2021 FY | 16.64 Billion SEK | -17.98% |
| 2021 Q4 | 16.64 Billion SEK | -3.5% |
| 2021 Q3 | 17.25 Billion SEK | -1.4% |
| 2021 Q1 | 18.96 Billion SEK | -6.55% |
| 2021 Q2 | 17.49 Billion SEK | -7.75% |
| 2020 FY | 20.29 Billion SEK | 24.64% |
| 2020 Q3 | 17.03 Billion SEK | -1.79% |
| 2020 Q4 | 20.29 Billion SEK | 19.18% |
| 2020 Q2 | 17.34 Billion SEK | 1.97% |
| 2020 Q1 | 17 Billion SEK | 4.43% |
| 2019 Q1 | 15.07 Billion SEK | 4.12% |
| 2019 FY | 16.28 Billion SEK | 12.46% |
| 2019 Q4 | 16.28 Billion SEK | 5.53% |
| 2019 Q2 | 15.67 Billion SEK | 3.96% |
| 2019 Q3 | 15.43 Billion SEK | -1.56% |
| 2018 Q1 | 13.14 Billion SEK | -7.25% |
| 2018 Q2 | 13.41 Billion SEK | 2.05% |
| 2018 Q3 | 13.57 Billion SEK | 1.18% |
| 2018 FY | 14.48 Billion SEK | 2.16% |
| 2018 Q4 | 14.48 Billion SEK | 6.66% |
| 2017 Q1 | 12.97 Billion SEK | -0.45% |
| 2017 Q4 | 14.17 Billion SEK | 6.85% |
| 2017 Q3 | 13.26 Billion SEK | -1.64% |
| 2017 Q2 | 13.48 Billion SEK | 3.98% |
| 2017 FY | 14.17 Billion SEK | 8.8% |
| 2016 Q4 | 13.02 Billion SEK | -0.89% |
| 2016 Q1 | 14.48 Billion SEK | -0.41% |
| 2016 FY | 13.02 Billion SEK | -10.39% |
| 2016 Q2 | 13.13 Billion SEK | -9.31% |
| 2016 Q3 | 13.14 Billion SEK | 0.11% |
| 2015 Q3 | 12.77 Billion SEK | 9.81% |
| 2015 Q4 | 14.53 Billion SEK | 13.81% |
| 2015 Q2 | 11.63 Billion SEK | 4.06% |
| 2015 Q1 | 11.18 Billion SEK | -3.91% |
| 2015 FY | 14.53 Billion SEK | 24.96% |
| 2014 Q3 | 10.57 Billion SEK | 2.08% |
| 2014 Q4 | 11.63 Billion SEK | 10.01% |
| 2014 Q2 | 10.36 Billion SEK | 1.52% |
| 2014 Q1 | 10.2 Billion SEK | -5.03% |
| 2014 FY | 11.63 Billion SEK | 8.26% |
| 2013 Q4 | 10.74 Billion SEK | 7.96% |
| 2013 FY | 10.74 Billion SEK | 5.11% |
| 2013 Q3 | 9.95 Billion SEK | -0.1% |
| 2013 Q2 | 9.96 Billion SEK | 1.31% |
| 2013 Q1 | 9.83 Billion SEK | -3.8% |
| 2012 Q4 | 10.22 Billion SEK | 15.02% |
| 2012 FY | 10.22 Billion SEK | 99.36% |
| 2012 Q1 | 6.13 Billion SEK | 19.54% |
| 2012 Q2 | 8.13 Billion SEK | 32.64% |
| 2012 Q3 | 8.89 Billion SEK | 9.32% |
| 2011 Q4 | 5.12 Billion SEK | -2.02% |
| 2011 Q1 | 5.08 Billion SEK | -3.53% |
| 2011 Q2 | 4.93 Billion SEK | -2.95% |
| 2011 Q3 | 5.23 Billion SEK | 6.08% |
| 2011 FY | 5.12 Billion SEK | -2.69% |
| 2010 FY | 5.27 Billion SEK | -2.32% |
| 2010 Q4 | 5.27 Billion SEK | 0.0% |
| 2009 FY | 5.39 Billion SEK | 19.91% |
| 2008 FY | 4.5 Billion SEK | 28.83% |
| 2007 FY | 3.49 Billion SEK | 2.25% |
| 2006 FY | 3.41 Billion SEK | 21.78% |
| 2005 FY | 2.8 Billion SEK | 68.67% |
| 2004 FY | 1.66 Billion SEK | 9.62% |
| 2003 FY | 1.51 Billion SEK | 20.59% |
| 2002 FY | 1.25 Billion SEK | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.34 Million USD | -919918.52% |
| Ansell Limited | 1.32 Billion USD | -1525.603% |
| Ansell Limited | 1.33 Billion USD | -1522.561% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 126.33 Million USD | -17012.066% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 943.17 Thousand USD | -2292058.8% |
| Psykey, Inc. | 2.47 Million USD | -873741.308% |
| ConvaTec Group Plc | 2.01 Billion USD | -971.231% |
| ConvaTec Group Plc | 2.02 Billion USD | -969.718% |
| Encision Inc. | 1.98 Million USD | -1089584.914% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 3.04 Million USD | -710939.28% |
| Innovative MedTech Inc. | 6.13 Million USD | -352296.956% |
| LifePoint, Inc. | 2.45 Million USD | -880809.179% |
| Medite Cancer Diagnostics, Inc. | 10.18 Million USD | -212246.528% |
| Paradigm Medical Industries, Inc. | 3.4 Million USD | -635752.941% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 3.04 Million USD | -710975.764% |
| Reflect Scientific, Inc. | 776.32 Thousand USD | -2784672.951% |
| SmileDirectClub, Inc. | 982.26 Million USD | -2100.943% |
| Sector 10, Inc. | 9.84 Million USD | -219484.156% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.35 Billion USD | -1494.667% |
| SheerVision, Inc. | 1.43 Million USD | -1510236.362% |
| United Health Products, Inc. | 1.99 Million USD | -1081461.623% |
| Vasamed, Inc. | 1 Million USD | -2150402.338% |
| Wearable Health Solutions, Inc. | 3.8 Million USD | -568778.387% |
| Yubo International Biotech Limited | 2.91 Million USD | -741820.517% |